Fixed- or Controlled-Dose Mycophenolate Mofetil with Standard- or Reduced-Dose Calcineurin Inhibitors: The Opticept Trial
Robert S. Gaston(University of Alabama at Birmingham), Bruce Kaplan(University of Arizona), T. Shah(Mendez National Institute of Transplantation), Diane M. Cibrik(University of Michigan–Ann Arbor), Les Shaw(University of Pennsylvania Health System), Michael Angelis(AdventHealth Orlando), S. Mulgaonkar(Saint Barnabas Medical Center), H.-U. Meier-Kriesche(University of Florida), Dharmesh Patel(La Roche College), Roy D. Bloom(University of Pennsylvania Health System)
Cited by 189Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis